About
QUIBIM is a pioneering AI-powered medical imaging biomarkers platform designed to unlock the full diagnostic and predictive potential of imaging data. Built on a secure, cloud-based, tissue-agnostic infrastructure, QUIBIM extracts key radiomics and deep features from the world's largest imaging data registries to support clinical research and healthcare decision-making. The platform includes specialized software-as-a-medical-device products: QP-Prostate® streamlines prostate MRI reads with PI-RADS-compliant AI analysis; QP-Brain® provides precise brain volumetry and white matter hyperintensity analysis for neurological diagnostics; QP-Liver® quantifies fat and iron concentration for comprehensive liver disease evaluation; QP-Breast® and QP-Lung® extend AI-driven analysis to breast and lung imaging; and QP-Insights® serves as a one-stop data management platform that harmonizes imaging data and links it with EHR and multi-omics information. For life sciences and biopharma partners, QUIBIM enables value-based collaborations to accelerate drug development, identify clinical trial candidates, and monitor treatment toxicity through validated AI models. The platform is ISO 27001:2022 certified, HIPAA and GDPR compliant, and leverages Microsoft Azure for secure, scalable data storage. With over 100K de-identified cancer patient records and millions of research imaging datasets, QUIBIM is trusted by oncologists, radiologists, neurologists, and clinical researchers globally.
Key Features
- Radiomics & Deep Feature Extraction: Automated extraction of radiomics and deep imaging features from MRI, CT, and PET scans to support clinical research and biomarker discovery.
- Specialized AI Medical Device Products: Suite of organ-specific AI tools (Prostate, Brain, Liver, Breast, Lung) that automate segmentation, quantification, and diagnostic decision support.
- QP-Insights® Data Management Platform: Centralizes, harmonizes, and indexes imaging data while integrating with EHR systems and multi-omics datasets for comprehensive research workflows.
- Life Sciences & Drug Development Support: AI models help biopharma partners identify clinical trial candidates, predict treatment response, and monitor toxicity and adverse events.
- Enterprise-Grade Security & Compliance: ISO 27001:2022 certified platform with end-to-end encryption, HIPAA and GDPR compliance, and Microsoft Azure cloud infrastructure.
Use Cases
- Radiologists using QP-Prostate® to automate and standardize prostate MRI reads with PI-RADS-compliant AI analysis.
- Neurologists leveraging QP-Brain® for brain volumetry and white matter hyperintensity analysis to support dementia or MS diagnosis.
- Hepatologists using QP-Liver® to quantify liver fat and iron concentration for early detection and monitoring of steatosis and iron overload.
- Biopharma companies partnering with QUIBIM to identify clinical trial candidates and monitor treatment response using AI imaging biomarkers.
- Hospital research teams using QP-Insights® to harmonize multi-site imaging datasets and integrate them with EHR data for real-world evidence studies.
Pros
- Clinically Validated AI Models: Products are software-as-a-medical-device solutions backed by published clinical research and real-world evidence from 230+ global sites.
- Comprehensive Organ Coverage: Dedicated AI modules for prostate, brain, liver, breast, and lung imaging provide broad clinical applicability across specialties.
- Strong Security & Regulatory Compliance: ISO 27001:2022 certification, HIPAA and GDPR compliance, and Azure-backed infrastructure ensure enterprise-level data protection.
- Large Proprietary Imaging Registry: Access to 100K+ de-identified cancer patients and millions of imaging datasets accelerates AI model training and validation.
Cons
- Enterprise-Focused Pricing: QUIBIM is primarily designed for healthcare institutions and biopharma companies, making it inaccessible for individual clinicians or small practices.
- Specialized Use Case: The platform is narrowly focused on medical imaging and clinical research, limiting its applicability outside of healthcare and life sciences.
- Integration Complexity: Connecting with existing PACS systems, EHR platforms, and multi-omics tools may require significant IT resources and onboarding time.
Frequently Asked Questions
What types of medical imaging does QUIBIM support?
QUIBIM supports MRI, CT, and PET scan data across multiple clinical areas including oncology, neurology, and liver disease.
Is QUIBIM compliant with healthcare data regulations?
Yes. QUIBIM is ISO 27001:2022 certified, and its data processing and storage are fully compliant with both HIPAA and GDPR regulations.
How does QUIBIM integrate with existing hospital systems?
QUIBIM's products, such as QP-Prostate®, are designed to integrate effortlessly with existing PACS systems, and QP-Insights® can link imaging data with EHR and multi-omics information.
Who are the primary users of QUIBIM?
QUIBIM serves radiologists, oncologists, neurologists, and clinical researchers at hospitals and imaging centers, as well as biopharma and life sciences companies running drug development programs.
What is QP-Insights® used for?
QP-Insights® is QUIBIM's data management platform that handles, indexes, stores, and harmonizes imaging data from various equipment manufacturers, minimizing variability and integrating it with clinical and omics data.
